Jones Edward Raymond 4
4 · Cytosorbents Corp · Filed Apr 27, 2018
Insider Transaction Report
Form 4
Jones Edward Raymond
Director
Transactions
- Award
Common Stock
2018-03-15+3,300→ 71,800 total - Award
Stock Option (right to buy)
2018-03-15+14,450→ 14,450 totalExercise: $7.90Exp: 2028-03-15→ Common Stock (14,450 underlying)
Footnotes (3)
- [F1]These shares represent restricted stock units and will be settled into common stock upon vesting upon a "Change in Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan").
- [F2]Includes (a) the following restricted stock units subject to vesting in accordance with the schedule set forth in (1) above: (i) 3,300 restricted stock units granted on March 15, 2018 and reported on this Form 4, (ii) 6,000 restricted stock units granted on February 24, 2017, (iii) 5,000 restricted stock units granted on June 7, 2016, and (iv) 55,000 restricted stock units granted on April 8, 2015, and (b) 2,500 shares of common stock owned by the reporting person.
- [F3]Such options were granted pursuant to the Plan and vest in four equal parts at the end of each calendar quarter beginning January 1, 2018.